Skip to content

Clinical trials

Phase 1/2 Osteosarcoma trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Osteosarcoma Phase: Phase 1/2 Country / region: United States Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20051
20081
20091
20101
20121
20132
20141
20151
20172
20182
20192
20201
20213
20232
20242
20252
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Recruiting11
Terminated5
Active, not recruiting3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center3
St. Jude Children's Research Hospital3
Children's Oncology Group2
Milton S. Hershey Medical Center2
National Cancer Institute (NCI)2
Bayer1
Celgene1
Cellestia Biotech AG1
City of Hope Medical Center1
Dana-Farber Cancer Institute1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Osteosarcoma30
Rhabdomyosarcoma14
Neuroblastoma13
Sarcoma13
Sarcoma, Ewing12
Rhabdoid Tumor6
Melanoma5
Neuroectodermal Tumors, Primitive, Peripheral5
Sarcoma, Synovial5
Wilms Tumor5

Trials

Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.